JP2009138000A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009138000A5 JP2009138000A5 JP2009018865A JP2009018865A JP2009138000A5 JP 2009138000 A5 JP2009138000 A5 JP 2009138000A5 JP 2009018865 A JP2009018865 A JP 2009018865A JP 2009018865 A JP2009018865 A JP 2009018865A JP 2009138000 A5 JP2009138000 A5 JP 2009138000A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound according
- converted
- compound
- under sufficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3237896P | 1996-12-06 | 1996-12-06 | |
| US60/032,378 | 1996-12-06 | ||
| US08/985,876 US6262283B1 (en) | 1996-12-06 | 1997-12-05 | Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds |
| US08/985,876 | 1997-12-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52401298A Division JP4441769B2 (ja) | 1996-12-06 | 1997-12-08 | アミノステロール、ビタミンｄ類似体および他の化合物の製造に有用な２４−ヒドロキシル化された化合物の立体選択的合成 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009138000A JP2009138000A (ja) | 2009-06-25 |
| JP2009138000A5 true JP2009138000A5 (enExample) | 2009-11-12 |
| JP5097724B2 JP5097724B2 (ja) | 2012-12-12 |
Family
ID=26708341
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52401298A Expired - Lifetime JP4441769B2 (ja) | 1996-12-06 | 1997-12-08 | アミノステロール、ビタミンｄ類似体および他の化合物の製造に有用な２４−ヒドロキシル化された化合物の立体選択的合成 |
| JP2009018865A Expired - Lifetime JP5097724B2 (ja) | 1996-12-06 | 2009-01-29 | アミノステロール、ビタミンｄ類似体および他の化合物の製造に有用な２４−ヒドロキシル化された化合物の立体選択的合成 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52401298A Expired - Lifetime JP4441769B2 (ja) | 1996-12-06 | 1997-12-08 | アミノステロール、ビタミンｄ類似体および他の化合物の製造に有用な２４−ヒドロキシル化された化合物の立体選択的合成 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6262283B1 (enExample) |
| EP (1) | EP0942918A2 (enExample) |
| JP (2) | JP4441769B2 (enExample) |
| AU (1) | AU746559B2 (enExample) |
| CA (1) | CA2272721C (enExample) |
| ES (1) | ES2486840T3 (enExample) |
| WO (1) | WO1998024800A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7410959B1 (en) | 2000-07-13 | 2008-08-12 | Genaera Corporation | Therapeutic uses for aminosterol compounds |
| WO2000009137A2 (en) * | 1998-08-12 | 2000-02-24 | Magainin Pharmaceuticals, Inc. | Aminosterol compounds and uses thereof |
| US6359012B1 (en) * | 1999-12-22 | 2002-03-19 | Bone Care International, Inc. | Method for making 24(S)-hydroxyvitamin D2 |
| DK1274718T3 (da) * | 2000-04-12 | 2007-02-12 | Genaera Corp | En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe |
| US7319112B2 (en) | 2000-07-14 | 2008-01-15 | The Procter & Gamble Co. | Non-halogenated antibacterial agents and processes for making same |
| WO2002020552A1 (en) * | 2000-09-08 | 2002-03-14 | Kuraray Co., Ltd. | Process for the preparation of pregnane derivatives |
| EP1431395B1 (en) | 2001-09-04 | 2008-12-10 | Kuraray Co., Ltd. | 7alpha-hydroxypregn-4-en-3-one-20-carbaldehyde, process for producing the same, and process for producing 7alpha,21-dihydroxy-20-methylpregn-4-en-3-one from the same |
| EP1470220B1 (en) * | 2002-01-10 | 2011-10-05 | Teva Pharmaceutical Industries, Ltd. | Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers |
| ATE390411T1 (de) * | 2004-03-18 | 2008-04-15 | Leo Pharma As | Stereoselektive synthese von vitamin-d-analoga |
| MY139521A (en) | 2004-03-18 | 2009-10-30 | Leo Pharma As | Stereoselective synthesis of vitamin d analogues |
| TWI299333B (en) * | 2004-07-01 | 2008-08-01 | Teva Pharma | Crystalline forms of 1,24(s)-dihydroxy vitamin d2 |
| US7557097B2 (en) * | 2004-11-20 | 2009-07-07 | Regents Of The University Of Minnesota | Structural, behavioral characterization, and synthesis of attractants for migratory lamprey |
| JPWO2006062129A1 (ja) * | 2004-12-08 | 2008-06-12 | 株式会社クラレ | （５α，７α）−３−スピロ−２’−（１’，３’−ジオキソラン）−２４−オキソコレスト−２２−エン−７−イルベンゾアートの製造方法 |
| TW200716136A (en) | 2005-04-25 | 2007-05-01 | Genaera Corp | Polymorphic and amorphous salt forms of squalamine dilactate |
| WO2008003619A2 (en) * | 2006-07-06 | 2008-01-10 | Ciba Holding Inc. | Encapsulated dispersions comprising electrophoretically mobile organic colorants |
| WO2008038965A1 (en) * | 2006-09-26 | 2008-04-03 | Kyungpook National University Industry-Academic Cooperation Foundation | 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient |
| US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| JOP20180077A1 (ar) | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
| US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| WO2009032321A2 (en) * | 2007-09-06 | 2009-03-12 | Genaera Corporation | A method for treating diabetes |
| KR100876857B1 (ko) * | 2008-02-15 | 2008-12-31 | 경북대학교 산학협력단 | 7-플루오로-3-아미노스테로이드 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 항균용 약학적 조성물 |
| US9127036B2 (en) | 2010-08-12 | 2015-09-08 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| US20130281420A1 (en) | 2010-08-17 | 2013-10-24 | Ohr Pharmaceutical, Inc. | Ophthalmic Formulations of Squalamine |
| US20130261317A1 (en) * | 2010-09-27 | 2013-10-03 | Kythera Biopharmaceuticals, Inc. | Methods for preparing synthetic bile acids and compositions comprising the same |
| CA3249322A1 (en) * | 2022-01-25 | 2023-08-03 | Enterin, Inc. | R and S C25 Isomeres of Aminosterols and Methods of Manufacture and Use |
| CN116836214B (zh) * | 2022-03-25 | 2024-07-09 | 苏州恩泰新材料科技有限公司 | 一种7-酮石胆酸中间体的合成方法和应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3016390A (en) | 1960-06-30 | 1962-01-09 | Searle & Co | N-(substituted alkyl) amino-5alpha-androstan-17beta-ols |
| US3370070A (en) | 1965-06-16 | 1968-02-20 | Searle & Co | [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones |
| GB1565351A (en) | 1975-06-02 | 1980-04-16 | Theramex | Steroid aminoethers |
| US4220598A (en) | 1977-11-14 | 1980-09-02 | Abbott Laboratories | Method and reagents for measuring the level of conjugated bile acids |
| US4550163A (en) | 1979-02-05 | 1985-10-29 | Abbott Laboratories | Ligand analog-irreversible enzyme inhibitor conjugates |
| US4372888A (en) | 1980-08-26 | 1983-02-08 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Nondenaturing zwitterionic detergents |
| JPS5842878B2 (ja) | 1981-12-02 | 1983-09-22 | 名糖産業株式会社 | １２−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用 |
| FR2523745B1 (fr) * | 1982-03-18 | 1987-06-26 | Bull Sa | Procede et dispositif de protection d'un logiciel livre par un fournisseur a un utilisateur |
| EP0101554B1 (en) | 1982-07-29 | 1986-10-15 | Lehner A.G. | New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same |
| US4994443A (en) | 1982-12-20 | 1991-02-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
| US5001116A (en) | 1982-12-20 | 1991-03-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
| IT1221734B (it) | 1983-02-24 | 1990-07-12 | Schiena Michele Giuseppe Di | Ursodesossicolico solfato acido sale sodico |
| US4545938A (en) | 1983-11-02 | 1985-10-08 | Beth Israel Medical Center | Chemical synthesis |
| US4917826A (en) | 1985-10-18 | 1990-04-17 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
| US4771042A (en) | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| JPS62175497A (ja) | 1986-01-28 | 1987-08-01 | Wakunaga Pharmaceut Co Ltd | 胆汁酸誘導体およびその製造法 |
| US5075464A (en) | 1987-04-22 | 1991-12-24 | Merrell Dow Pharmaceuticals Inc. | 17β-(cyclopropylamino)androstene derivatives |
| SE8702254D0 (sv) | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
| US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
| US5135919A (en) | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
| IT1229570B (it) | 1989-04-17 | 1991-09-04 | Giuliani Spa | Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. |
| IT1229569B (it) | 1989-04-17 | 1991-09-04 | Giuliani Spa | Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. |
| JPH07116215B2 (ja) | 1989-04-19 | 1995-12-13 | エスエス製薬株式会社 | 新規なステロイド化合物 |
| PT93847A (pt) | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
| US4966897A (en) | 1989-08-15 | 1990-10-30 | Merrell Dow Pharmaceuticals Inc. | 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
| US5004737A (en) | 1989-09-22 | 1991-04-02 | Pacific Chemical Co., Ltd. | Quaternary ammonium-substituted sterol derivatives |
| EP0466315A3 (en) | 1990-05-30 | 1992-07-01 | Larrian Gillespie | Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation |
| AU657690B2 (en) | 1990-06-11 | 1995-03-23 | Alcon Laboratories, Inc. | Steroids which inhibit angiogenesis |
| NZ240846A (en) | 1990-12-06 | 1994-04-27 | Hoechst Ag | Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions |
| US5192756A (en) | 1992-03-18 | 1993-03-09 | The Children's Hospital Of Pennsylvania | Aminosterol antibiotic |
| WO1993025197A1 (en) | 1992-06-12 | 1993-12-23 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
| US5247104A (en) | 1992-11-04 | 1993-09-21 | Wisconsin Alumni Research Foundation | Preparation of 1α, 24-dihydroxyvitamin D analogs |
| JPH06329679A (ja) * | 1993-01-20 | 1994-11-29 | Nissan Chem Ind Ltd | 光学活性β−アミノアルコキシボラン錯体 |
| WO1994019366A1 (en) | 1993-02-26 | 1994-09-01 | Magainin Pharmaceuticals Inc. | Chemical synthesis of squalamine |
| DE69412596T2 (de) | 1993-03-10 | 1999-03-04 | Magainin Pharmaceuticals Inc., Plymouth Meeting, Pa. | Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel |
| EP0749437B1 (en) | 1994-03-10 | 2001-12-05 | Magainin Pharmaceuticals Inc. | Pharmaceutical uses of steroid derivatives |
| PT832094E (pt) * | 1995-06-07 | 2004-06-30 | Genaera Corp | Compostos de aminoesterol uteis como inibidores do permutador sodio/protao )nhe) metodos e composicoes farmaceuticas empregando estes inibidores e processos para avaliacao da eficacia inibidora de nhe dos compostos |
| US5792635A (en) * | 1995-06-07 | 1998-08-11 | Magainin Pharmaceuticals, Inc. | Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine |
| US5623546A (en) * | 1995-06-23 | 1997-04-22 | Motorola, Inc. | Encryption method and system for portable data |
| JP3860214B2 (ja) | 1996-04-29 | 2006-12-20 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | トースター |
-
1997
- 1997-12-05 US US08/985,876 patent/US6262283B1/en not_active Expired - Lifetime
- 1997-12-08 CA CA002272721A patent/CA2272721C/en not_active Expired - Lifetime
- 1997-12-08 JP JP52401298A patent/JP4441769B2/ja not_active Expired - Lifetime
- 1997-12-08 EP EP97952256A patent/EP0942918A2/en not_active Ceased
- 1997-12-08 ES ES03011093.6T patent/ES2486840T3/es not_active Expired - Lifetime
- 1997-12-08 AU AU55914/98A patent/AU746559B2/en not_active Ceased
- 1997-12-08 WO PCT/US1997/022031 patent/WO1998024800A2/en not_active Ceased
-
2001
- 2001-04-12 US US09/833,055 patent/US6610866B2/en not_active Expired - Lifetime
-
2009
- 2009-01-29 JP JP2009018865A patent/JP5097724B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4691557A3 (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| JP2011518833A5 (enExample) | ||
| EP2248805A3 (en) | Method of synthesis of bosentan, its polymorphic forms and its salts | |
| PT2453739E (pt) | Processo para a preparação de uma suspensão aquosa de um composto pesticida orgânico | |
| JP2009149903A5 (enExample) | ||
| WO2010080242A3 (en) | Uzm-27 family of crystalline aluminosilicate compositions, a method of preparing the compositions and methods of using the compositions | |
| JP2015129106A5 (enExample) | ||
| WO2011022596A3 (en) | Preparation of bazedoxifene and its salts | |
| WO2010070658A3 (en) | Improved process for the preparation of endothelin receptor antagonists | |
| JP2009179634A5 (enExample) | ||
| WO2011075701A3 (en) | Methods for the purification of deoxycholic acid | |
| WO2010001257A3 (en) | Novel solid state forms of laquinimod and its sodium salt | |
| WO2011004402A3 (en) | Improved process for the preparation of ambrisentan and novel intermediates thereof | |
| JP2011511794A5 (ja) | 塩の製造のための方法 | |
| WO2013014665A8 (en) | Intermediate compounds and process for the preparation of lurasidone and salts thereof | |
| JP2015532645A5 (enExample) | ||
| WO2010004575A3 (en) | Preparation of escitalopram, its salts and intermediates | |
| EP2455372A4 (en) | PROCESS FOR THE PRODUCTION OF POLYMORPHIC 2- (3-CYANO-4-ISOBUTYLOXYPHENYL) -4-METHYL-5-THIAZOLECABOXYLIC ACID CRYSTALS BY A METHOD OF ADDITION OF A MEDIOCOUS SOLVENT | |
| ATE500226T1 (de) | Aripiprazolhemifumarat und verfahren zu dessen herstellung | |
| WO2011004387A3 (en) | Process for the preparation of dexlansoprazole polymorphic forms | |
| JP2018009003A5 (enExample) | ||
| JP2017533926A5 (enExample) | ||
| JP2017509581A5 (enExample) | ||
| WO2009060297A3 (en) | An improved process for the preparation of paliperidone and its intermediates | |
| JP2013241421A5 (enExample) |